Form4insider filings, from the source

SEC Form 4 · accession 0001077183-18-000030

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
George Cardoza
Officer — President, Pharma Services
Period of report
May 25, 2018
Accepted (ET)
May 29, 2018 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 25, 2018M8,333$0.00A197,422D
Common Stockholding———20,000ITrust by Self

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted StockF1,F2,F3$0.00May 25, 2018M8,333DMay 25, 2018—Common Stock8,33316,667D
Stock Option (Right to Buy)F4$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock200,000200,000D
Stock Option (Right to Buy)F5$3.45holding———Mar 5, 2015Mar 5, 2019Common Stock30,00030,000D
Stock Option (Right to Buy)F6$4.78holding———May 4, 2016May 4, 2020Common Stock200,000200,000D
Stock Option (Right to Buy)F7$7.52holding———Apr 28, 2018Apr 28, 2022Common Stock200,000200,000D
Stock Options (Right to Buy)F8$8.03holding———Feb 26, 2019Feb 26, 2023Common Stock192,500192,500D

Explanation of responses